published meta-analysis   sensitivity analysis   studies

vitamin C in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias hospitalizationdetailed resultsBengu, 2020 0.59 [0.01; 30.23] 0.59[0.01; 30.23]Bengu, 202010%113NAnot evaluable new illness compatible with Covid-19 detailed resultsBengu, 2020 0.08 [0.01; 0.77] 0.08[0.01; 0.77]Bengu, 202010%113NAnot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2024-03-29 16:21 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 523,885 - roots T: 290